Sign In
Buy INJUSD
$6.40
-0.110 (-1.69%)
At Close: Jun 03, 2026
Injective (INJ) Surges 6.47% to $15.30 as Strategic Partnerships Drive Bullish Momentum
05:54am, Sunday, 27'th Jul 2025
INJ trades at $15.30 with 6.47% gains as yield-bearing stablecoin integrations and technical breakouts signal continued bullish momentum toward $15.71 resistance.
Injective (INJ) Surges 6.38% as Bulls Defend Key Support Above $14
12:13am, Saturday, 26'th Jul 2025
INJ trades at $14.18 (+6.38% daily) as technical breakout momentum continues following last week's 14% surge, with bulls targeting $15.71 resistance level.
Injective Launches SBET as First Onchain Digital Treasury
07:04am, Friday, 25'th Jul 2025
This move transforms a traditional corporate crypto reserve into an active, yield-generating instrument that can be used across DeFi applications. Built using Injective's iAssets framework, SBET intro
Injective launches SBET, the first onchain Digital Asset Treasury
04:00am, Friday, 25'th Jul 2025
Injective has launched SBET, the first onchain Digital Asset Treasury, marking a major milestone for its iAssets framework and the growing ecosystem of tokenized real-world assets.
Injective Powers First Onchain Treasury with $1B ETH via SharpLink's $SBET
12:58am, Friday, 25'th Jul 2025
SharpLink's $SBET unlocks staked ETH reserves via Injective's programmable Digital Asset Treasury system.
Injective (INJ) Tests $13.31 Support After Breaking Multi-Week Downtrend
12:13am, Friday, 25'th Jul 2025
INJ trades at $13.31 (-1.48% in 24h) as bulls defend key support following last week's 14% surge driven by EVM testnet launch and major partnerships.
Injective is tokenizing shares of prominent ETH treasury company SharpLink
03:24pm, Thursday, 24'th Jul 2025
Injective said it is bringing SBET, the stock for Joe Lubin's Ethereum treasury firm SharpLink, onchain, “marking the first tokenized digital asset treasury."
Injective (INJ) Holds Above $13 as Bulls Eye $15.71 Resistance Target
01:32pm, Thursday, 24'th Jul 2025
INJ trades at $13.92 (+0.58% daily) with strong bullish momentum intact following recent 14% surge and technical breakout above key resistance levels.
Top Altcoins To Buy Today As Crypto Market Cools Before Next Bull Run
11:58am, Thursday, 24'th Jul 2025
Top altcoins like ARB, ONDO, XLM, HBAR, and INJ are setting up for the next breakout as the market cools ahead of a renewed altseason push. In Brief: The Altcoin Season Index has dropped to 43, offeri
Injective brings SharpLink's $1.3 billion ETH treasury fully on-chain
10:51am, Thursday, 24'th Jul 2025
Injective's on-chain treasury innovation could accelerate institutional adoption of DeFi, enhancing capital efficiency and market transparency. The post Injective brings SharpLink's $1.3 billion ETH t
Crypto Price Analysis 7-23: BITCOIN: BTC, ETHEREUM: ETH, SOLANA: SOL, POLKADOT: DOT, DOGWIFHAT: WIF, INJECTIVE: INJ
09:32am, Wednesday, 23'rd Jul 2025
The crypto market rebounded after Monday's wobble as Bitcoin (BTC) and other altcoins registered strong recoveries. BTC slipped below $117,000 on Tuesday but recovered, reaching a high of $120,265 dur
Injective (INJ) Maintains Bullish Momentum Near $15 After 14% Surge
08:14pm, Monday, 21'st Jul 2025
INJ trades at $14.83 with strong bullish signals as technical breakout and strategic partnerships drive sustained momentum toward $15.71 resistance level.
Injective (INJ) Breaks $15 Resistance as Bulls Target $15.48 on EVM Testnet Momentum
11:51pm, Sunday, 20'th Jul 2025
INJ surges to $15.19 (+6.75%) breaking multi-week downtrend with RSI at 72.96 showing overbought conditions as EVM testnet launch and strategic partnerships fuel bullish momentum.
Injective (INJ) Surges 14% Above Resistance as Bulls Target $15.48 - Technical Breakout Analysis
12:52am, Sunday, 20'th Jul 2025
Injective breaks multi-week downtrend with strong momentum, trading at $14.23 after key resistance breakouts. Technical indicators signal continued bullish momentum.
Injective (INJ) Surges 15% on EVM Testnet Launch and Strategic Partnerships: Technical Analysis & Price Outlook
03:15am, Saturday, 19'th Jul 2025
Injective rallies 15% following EVM testnet launch and partnerships with Google Cloud and Deutsche Telekom. Technical indicators suggest continued bullish momentum.
